Dual Antithrombotic Therapy with Oral Anticoagulant and P2Y12 inhibitors in Patients with Atrial Fibrillation After Percutaneous Coronary Intervention.

Hideki Kitahara,Daichi Yamashita,Takanori Sato,Sakuramaru Suzuki,Takashi Hiraga,Tatsuro Yamazaki,Tadahiro Matsumoto,Takahiro Kobayashi,Yuji Ohno, Junya Harada,Kenichi Fukushima, Tatsuhiko Asano,Naoki Ishio, Raita Uchiyama, Hirofumi Miyahara,Shinichi Okino, Masanori Sano,Nehiro Kuriyama,Masashi Yamamoto,Naoya Sakamoto,Junji Kanda,Yoshio Kobayashi

Journal of cardiology（2023）

引用 0|浏览8

暂无评分

摘要

In AF patients undergoing PCI, DAT was associated with lower incidence of MACE and major bleeding events compared with TAT. In comparison of P2Y12i, there might be no significant difference in the incidence of MACE and bleeding events between prasugrel-based DAT and clopidogrel-based DAT.

查看译文

关键词

atrial fibrillation,oral anticoagulant,dual antithrombotic therapy,p2y12 inhibitors,percutaneous coronary intervention

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要